Clinical Trial: Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naive Adults With Human Immunodeficiency Virus Type 1 (HIV-1)

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711223) titled 'Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naive Adults With Human Immunodeficiency Virus Type 1 (HIV-1)' on July 07.

Brief Summary: This study employs a multicenter, randomized, double-blind, double-dummy, active-controlled, parallel-group, non-inferiority design. The trial will be conducted in treatment-naive adult patients with HIV-1, using Dolutegravir Sodium Tablets as the control, to demonstrate the efficacy and safety of the core investigational drug ACC017 combined with FTC/TAF Tablets (II) compared to Dolutegravir Sodium combined with FTC/TAF Tablets (II) in treating treatme...